Cargando…
Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols
Early anecdotal reports and preliminary studies suggested that cannabinoid-based medicines such as delta-9-tetrahydrocannabinol (THC) are effective in the treatment of Gilles de la Tourette syndrome (TS). We report a single case study of a patient with otherwise treatment-resistant TS successfully t...
Autores principales: | Kanaan, Ahmad Seif, Jakubovski, Ewgeni, Müller-Vahl, Kirsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447929/ https://www.ncbi.nlm.nih.gov/pubmed/28445405 http://dx.doi.org/10.3390/brainsci7050047 |
Ejemplares similares
-
Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome
por: Gerasch, Sarah, et al.
Publicado: (2016) -
Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients
por: Jakubovski, Ewgeni, et al.
Publicado: (2017) -
Tic Reduction in Adult Onset Gilles De La Tourette Syndrome Using as Required Nabiximols Spray
por: Schwittay, Maximilian A., et al.
Publicado: (2021) -
New Insights into Clinical Characteristics of Gilles de la Tourette Syndrome: Findings in 1032 Patients from a Single German Center
por: Sambrani, Tanvi, et al.
Publicado: (2016) -
Non-just-right experiences are more closely related to OCD than tics in Tourette patients
por: Brandt, Valerie, et al.
Publicado: (2023)